Cullinan Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGEM and other ETFs, options, and stocks.About CGEM
Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617.
CGEM Key Statistics
Stock Snapshot
With a market cap of 931.7M, Cullinan Therapeutics(CGEM) trades at $15.16. The stock has a price-to-earnings ratio of -3.96.
On 2026-05-12, Cullinan Therapeutics(CGEM) stock traded between a low of $14.58 and a high of $15.20. Shares are currently priced at $15.16, which is +4.0% above the low and -0.3% below the high.
The Cullinan Therapeutics(CGEM)'s current trading volume is 176.95K, compared to an average daily volume of 896.26K.
In the last year, Cullinan Therapeutics(CGEM) shares hit a 52-week high of $16.74 and a 52-week low of $5.68.
In the last year, Cullinan Therapeutics(CGEM) shares hit a 52-week high of $16.74 and a 52-week low of $5.68.
Analyst ratings
100%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.